rs12420618 - SIPA1
Magnitude 2.2 · 1 study on file
Reported associations
-
Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes - Unknown journal (n.d.) · Unknown authors · PubMed 39379762
ABSTRACT: Type 2 diabetes (T2D) genome-wide association studies (GWASs) often overlook rare variants as a result of previous imputation panels' limitations and scarce whole-genome sequencing (WGS) data. We used TOPMed imputation and WGS to conduct the largest T2D GWAS meta-analysis involving 51,256 cases of T2D and 370,487 controls, targeting variants with a minor allele frequency as low as 5 × 10−5. We identified 12 new variants, including a rare African/African American-enriched enhancer variant near the LEP gene (rs147287548), associated with fourfold increased T2D risk. We also identified a rare missense variant in HNF4A (p.Arg114Trp), associated with eightfold increased T2D risk, previously reported in maturity-onset diabetes of the young with reduced penetrance, but observed
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Bloodwork
-
Fasting glucose and HbA1c Moderate
Identify early glucose metabolism changes associated with genetic risk
Baseline fasting glucose, then HbA1c every 1-2 years
Discuss with your doctor
-
Type 2 diabetes risk and screening options Moderate
GWAS variant associated with increased Type 2 diabetes risk
Discuss with healthcare provider
Screening
-
Earlier or more frequent glucose monitoring Moderate
Genetic association with elevated Type 2 diabetes risk
Discuss timing with healthcare provider